174 related articles for article (PubMed ID: 29408023)
21. Psoromic Acid, a Lichen-Derived Molecule, Inhibits the Replication of HSV-1 and HSV-2, and Inactivates HSV-1 DNA Polymerase: Shedding Light on Antiherpetic Properties.
Hassan STS; Šudomová M; Berchová-Bímová K; Šmejkal K; Echeverría J
Molecules; 2019 Aug; 24(16):. PubMed ID: 31405197
[TBL] [Abstract][Full Text] [Related]
22. A core extended naphtalene diimide G-quadruplex ligand potently inhibits herpes simplex virus 1 replication.
Callegaro S; Perrone R; Scalabrin M; Doria F; Palù G; Richter SN
Sci Rep; 2017 May; 7(1):2341. PubMed ID: 28539620
[TBL] [Abstract][Full Text] [Related]
23. Hypericin blocks the function of HSV-1 alkaline nuclease and suppresses viral replication.
Cao K; Zhang Y; Yao Q; Peng Y; Pan Q; Jiao Q; Ren K; Sun F; Zhang Q; Guo R; Zhang J; Chen T
J Ethnopharmacol; 2022 Oct; 296():115524. PubMed ID: 35811028
[TBL] [Abstract][Full Text] [Related]
24. Cell culture replication of herpes simplex virus and, or human cytomegalovirus is inhibited by 3,7-dialkoxylated, 1-hydroxyacridone derivatives.
Lowden CT; Bastow KF
Antiviral Res; 2003 Aug; 59(3):143-54. PubMed ID: 12927304
[TBL] [Abstract][Full Text] [Related]
25. Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication.
Bryant KF; Yan Z; Dreyfus DH; Knipe DM
J Virol; 2012 Jun; 86(12):6825-34. PubMed ID: 22491472
[TBL] [Abstract][Full Text] [Related]
26. MG132 exerts anti-viral activity against HSV-1 by overcoming virus-mediated suppression of the ERK signaling pathway.
Ishimaru H; Hosokawa K; Sugimoto A; Tanaka R; Watanabe T; Fujimuro M
Sci Rep; 2020 Apr; 10(1):6671. PubMed ID: 32317666
[TBL] [Abstract][Full Text] [Related]
27. Pressurized DNA state inside herpes capsids-A novel antiviral target.
Brandariz-Nuñez A; Robinson SJ; Evilevitch A
PLoS Pathog; 2020 Jul; 16(7):e1008604. PubMed ID: 32702029
[TBL] [Abstract][Full Text] [Related]
28. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
29. Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.
Thomsen DR; Oien NL; Hopkins TA; Knechtel ML; Brideau RJ; Wathen MW; Homa FL
J Virol; 2003 Feb; 77(3):1868-76. PubMed ID: 12525621
[TBL] [Abstract][Full Text] [Related]
30. The structure and function of the HSV DNA replication proteins: defining novel antiviral targets.
Matthews JT; Terry BJ; Field AK
Antiviral Res; 1993 Feb; 20(2):89-114. PubMed ID: 8384825
[TBL] [Abstract][Full Text] [Related]
31. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
32. The structure of the herpes simplex virus DNA-packaging terminase pUL15 nuclease domain suggests an evolutionary lineage among eukaryotic and prokaryotic viruses.
Selvarajan Sigamani S; Zhao H; Kamau YN; Baines JD; Tang L
J Virol; 2013 Jun; 87(12):7140-8. PubMed ID: 23596306
[TBL] [Abstract][Full Text] [Related]
33. Zinc Sulfate in Narrow Range as an In Vitro Anti-HSV-1 Assay.
Fani M; Khodadad N; Ebrahimi S; Nahidsamiei R; Makvandi M; Teimoori A; Langari H
Biol Trace Elem Res; 2020 Feb; 193(2):410-413. PubMed ID: 31028520
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of dual-specificity tyrosine phosphorylation-regulated kinases (DYRK) exert a strong anti-herpesviral activity.
Hutterer C; Milbradt J; Hamilton S; Zaja M; Leban J; Henry C; Vitt D; Steingruber M; Sonntag E; Zeitträger I; Bahsi H; Stamminger T; Rawlinson W; Strobl S; Marschall M
Antiviral Res; 2017 Jul; 143():113-121. PubMed ID: 28400201
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol.
Liu S; Li L; Tan L; Liang X
Virol Sin; 2019 Jun; 34(3):315-323. PubMed ID: 30915606
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of herpes simplex virus replication by WAY-150138: assembly of capsids depleted of the portal and terminase proteins involved in DNA encapsidation.
Newcomb WW; Brown JC
J Virol; 2002 Oct; 76(19):10084-8. PubMed ID: 12208991
[TBL] [Abstract][Full Text] [Related]
37. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
[TBL] [Abstract][Full Text] [Related]
38. Qualitative Differences in Capsidless L-Particles Released as a By-Product of Bovine Herpesvirus 1 and Herpes Simplex Virus 1 Infections.
Russell T; Bleasdale B; Hollinshead M; Elliott G
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185590
[TBL] [Abstract][Full Text] [Related]
39. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
[TBL] [Abstract][Full Text] [Related]
40. Short hairpin-loop-structured oligodeoxynucleotides reduce HSV-1 replication.
Falkenhagen A; Heinrich J; Moelling K
Virol J; 2009 Apr; 6():43. PubMed ID: 19397793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
